PU

PURE Biosciences IncOOTC PURE Stock Report

Last reporting period 30 Apr, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

0.009

Micro

Exchange

OOTC - OTC

PURE Stock Analysis

PU

Uncovered

PURE Biosciences Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-38/100

Low score

Market cap $B

0.009

Dividend yield

Shares outstanding

111.36 B

PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. The company is headquartered in Rancho Cucamonga, California and currently employs 15 full-time employees. The firm's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate ( SDC). SDC is a non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. The firm's products include PURE Hard Surface Disinfectant and Sanitizer, PURE Complete Solution, PURE Multi-Purpose and Floor Cleaner Concentrate, PURE Multi-Purpose Hi-Foam Cleaner Concentrate, Axen 30, Axenohl and SILVERION. PURE Complete Solution is comprised of PURE Hard Surface and cleaning products. The PURE Complete Solution offers cleaning, disinfecting and sanitizing product line to end-users including foodservice, food manufacturing and food processing customers.

View Section: Eyestock Rating